Research Suggests Statins Could Lower Ovarian Cancer Risk

February 18, 2020 10:00 am

By Cancer Research UK

A genetic study has found evidence to suggest that women who take statins in the long term could be less likely to develop ovarian cancer, according to new research funded by Cancer Research UK published today … Read more

Simple Blood Test Measures the Body’s Immune Response to Improve Ovarian Cancer Diagnosis

February 17, 2020 10:00 am

Researchers have developed a simple blood test that measures the body’s own immune response to improve diagnosis of ovarian cancer.

Ovarian cancer is one of the most common gynecologic cancers, with the highest mortality rate. About 300,000 new cases are … Read more

Higher Risk of Ovarian Clear Cell Cancer in Asian Pacific Islanders

February 14, 2020 10:00 am

By Christina Bennett, MS

Regardless of birthplace, women who are Asian Pacific Islanders may have a higher risk of developing ovarian clear cell cancer compared with other ethnicities, according to a population-based retrospective cohort study. The findings were recently published … Read more

Study Shows “Self-eating” Genes may Act as Tumor Suppressors in Ovarian Cancer

February 13, 2020 10:00 am

By Peter Hofland, Ph.D

Scientists at the Medical University of South Carolina (MUSC) and the University of California at San Diego (UCSD) are shedding light on a decades-old controversy, showing that autophagy or “self-eating” genes work against tumors … Read more

Supercharged Cancer Cells Outrun Chemo, Race toward Immunotherapy

February 7, 2020 10:00 am

Cancer cells operate in mutational overdrive, which allows them to blow past chemotherapy and other would-be enforcers of physiological order. Cancer’s speeding, however, may prove to be a vulnerability, say scientists from the Mayo Clinic, the Institute of Cancer Research, … Read more

ASCO Guideline: Germline Testing Recommended for All Women Diagnosed With Epithelial Ovarian Cancer

February 6, 2020 11:00 am

By Susan Moench, PhD, PA-C

A central tenant of a recently issued American Society of Clinical Oncology (ASCO) guideline is that all women with a diagnosis of epithelial ovarian cancer should be offered testing for specific germline mutations associated with … Read more

Psychedelic Mushrooms Can Help Ease Anxiety and Depression in Cancer Patients for Years, Scientists Believe

February 3, 2020 11:00 am

By Kashmira Gander

Taking a single dose of a psychedelic compound found in magic mushrooms can ease symptoms of anxiety and depression in cancer patients for years, according to a study.

Almost five years after taking the compound psilocybin while … Read more

Researchers find cancer-fighting potential in non-cancer drugs

January 28, 2020 11:00 am

By Julie Steenhuysen

(Reuters Health) – U.S. researchers who tested the cancer-fighting properties of more than 4,500 non-cancer drugs found nearly 50 drugs for other conditions showed at least some cancer-killing ability.

“We found that a surprising number of non-oncology … Read more

Tweaking how CAR-T therapy kills tumors could stop a dangerous side effect, study finds

January 28, 2020 10:00 am

By Sharon Begley

As every trauma surgeon knows, there are messy bullet wounds and there are neat ones, and the former cause incomparably more trouble. If a team of scientists in China is right, the same principle may explain why … Read more

Use of intrauterine devices may decrease risk for ovarian cancer

January 24, 2020 10:00 am

About 14,000 women each year die of ovarian cancer, making it one of the deadliest gynecologic cancers.

Moreover, 80% of ovarian cancer diagnoses occur only after the disease has progressed to a late stage. The Ovarian Cancer Research Alliance estimated … Read more

“One-size-fits-all” cancer treatment could be on the horizon after scientists discover new immune cell by accident

January 24, 2020 10:00 am

By Kashmira Gander

Scientists have discovered a new cell in the immune system that can kill many types of cancer, which they hope could one day be used to create a “one size fits all” treatment for the disease.

In … Read more

PALB2 Linked to Increased Risk for Breast, Ovarian, and Pancreatic Cancer

January 8, 2020 10:00 am

By Christina Bennett, MS

Germline PALB2 pathogenic variants were associated with an increased risk for female breast cancer, male breast cancer, ovarian cancer, and pancreatic cancer, and these risks varied by age, according to data from an international study … Read more

Talc Powder Not Linked to Ovarian Cancer in Prospective Datasets

January 7, 2020 5:00 pm

By Ian Ingram

— With some 250,000 participants, study rules out all but smallest risk increases

New research on a quarter-million women from four U.S. cohorts found no significant association between ovarian cancer and the use of powder-based products in … Read more

Clearity Launches Unique Trial Finder That Displays Results For Clinical Trials Retrieved By Search

December 31, 2019 3:00 pm

Clearity’s Clinical Trial Finder is a personalized and online search tool that will help you to find a clinical trial based on your location or clinical situation (i.e. platinum sensitive or platinum resistant, number of previous treatments). We can also … Read more

Carmel Valley Doctor Joins Clearity Foundation Board in the Fight Against Ovarian Cancer

December 30, 2019 1:00 pm

By Jeanne Rawdin

“Elegant science” are not two words you hear put together very often. But for Carmel Valley resident Dr. Pamila Brar the phrase sums up her life’s career goals. Brar sees elegant science as “the promise of precision … Read more

Overcoming Appointment Anxiety

December 27, 2019 5:00 pm

This article discusses the anxiety that often surrounds routine appointments, as well as daily life, after a cancer diagnosis. Steps Through OC offers free, professional ovarian cancer counseling for women, families and caregivers coping with ovarian cancer. Our goal is Read more

Weekly Dose-Dense Chemo Not Recommended in First-Line Epithelial Ovarian Cancer Treatment

December 20, 2019 6:00 pm

By Matthew Fowler

Weekly dose-dense paclitaxel as a frontline treatment for patients with epithelial ovarian cancer was not found to significantly improve progression-free survival (PFS) compared to the standard 3-weekly chemotherapy, according to results from the ICON8 study published in … Read more

Siravatinib/Tislelizumab Signals Efficacy in Patients With Platinum-Resistant Ovarian Cancer

December 19, 2019 6:00 pm

By Nichole Tucker

Preliminary data showed that the combination of sitravatinib (MGCD516) and tislelizumab (BGB-A317) is well tolerated and may promote antitumor activity when administered to patients with platinum-resistant ovarian cancer, according to a press release from BieGene, Ltd, which … Read more

Endometriosis Appears to Have No Effect on Ovarian Cancer Outcomes, But More Research Needed, Study Says

December 17, 2019 3:00 pm

By Marissa Wexler, MS

Endometriosis does not seem to significantly affect ovarian cancer prognosis and survival in patients of reproductive age, a small study suggests.

However, more research is needed to identify factors associated with the progression of endometriosis to … Read more

Small, Thin Metal Mesh Loaded With T Cells Shrinks Tumors in Ovarian Cancer Models

December 9, 2019 6:00 pm

What if a metal that’s already used to repair broken bones, straighten teeth and keep arteries from clogging could also be used to stop your cancer from spreading?

New findings published Dec. 9 in Nature Biomedical Engineering from scientists at … Read more